Handelsbanken Fonder’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $723K | Sell |
6,358
-300
| -5% | -$34.1K | ﹤0.01% | 1092 |
|
|
2025
Q1 | $700K | Buy |
6,658
+800
| +14% | +$84.1K | ﹤0.01% | 1097 |
|
|
2024
Q4 | $628K | Buy |
5,858
+500
| +9% | +$53.6K | ﹤0.01% | 1196 |
|
|
2024
Q3 | $536K | Buy |
5,358
+500
| +10% | +$50K | ﹤0.01% | 1211 |
|
|
2024
Q2 | $409K | Buy |
4,858
+1,200
| +33% | +$101K | ﹤0.01% | 1243 |
|
|
2024
Q1 | $267K | Hold |
3,658
| – | – | ﹤0.01% | 1426 |
|
|
2023
Q4 | $261K | Hold |
3,658
| – | – | ﹤0.01% | 1433 |
|
|
2023
Q3 | $219K | Hold |
3,658
| – | – | ﹤0.01% | 1437 |
|
|
2023
Q2 | $264K | Buy |
+3,658
| New | +$264K | ﹤0.01% | 1396 |
|
|
2022
Q3 | – | Sell |
-5,062
| Closed | -$282K | – | 1575 |
|
|
2022
Q2 | $282K | Hold |
5,062
| – | – | ﹤0.01% | 1360 |
|
|
2022
Q1 | $355K | Hold |
5,062
| – | – | ﹤0.01% | 1422 |
|
|
2021
Q4 | $488K | Buy |
5,062
+962
| +23% | +$92.7K | ﹤0.01% | 1366 |
|
|
2021
Q3 | $356K | Hold |
4,100
| – | – | ﹤0.01% | 1533 |
|
|
2021
Q2 | $336K | Buy |
4,100
+320
| +8% | +$26.2K | ﹤0.01% | 1594 |
|
|
2021
Q1 | $359K | Sell |
3,780
-2,404
| -39% | -$228K | ﹤0.01% | 1367 |
|
|
2020
Q4 | $384K | Hold |
6,184
| – | – | ﹤0.01% | 1294 |
|
|
2020
Q3 | $368K | Hold |
6,184
| – | – | ﹤0.01% | 1145 |
|
|
2020
Q2 | $432K | Buy |
+6,184
| New | +$432K | ﹤0.01% | 1029 |
|